Genetic analysis of 18 families with tuberous sclerosis complex
- 21 May 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in neurogenetics
- Vol. 23 (3), 1-8
- https://doi.org/10.1007/s10048-022-00694-5
Abstract
Tuberous sclerosis complex (TSC) is mainly caused by variants in TSC1 and TSC2, which encodes hamartin protein and tuberin protein, respectively. Here, we report clinical and molecular characteristics of 18 families with TSC. High-throughput DNA sequencing was employed to detect variants in all the exons and flanking region of TSC1 and TSC2. TA clone and real-time PCR were performed to verify the pathogenicity of candidate variants. A total of 17 mutations were identified, including 13 mutations in TSC2 and 4 mutations in TSC1. Fifty-six percent (10/18) of the families carried de novo mutations, and 8 of these mutations were not reported previously. Most mutations detected were loss-of-function mutations (15/17). One splice-site mutation (TSC2 c.599 + 5G > A) caused abnormal splicing and was confirmed by in vitro analysis. Facial angiofibromas (94%) and epilepsy (89%) were the most prevalent clinical features in our patients. Treatment with anti-seizure medication (ASM) or in combination with rapamycin results in clinical remission in most patients with TSC-associated seizures (14/15). For genotype–phenotype correlation, patients in our cohort with TSC2 mutations had an earlier onset age and patients with TSC1 showed better response to ASM. Our study has expanded the spectrum of TSC1 and TSC2 causing TSC.This publication has 34 references indexed in Scilit:
- The natural history of epilepsy in tuberous sclerosis complexEpilepsia, 2010
- Recent advances in neurobiology of Tuberous Sclerosis ComplexBrain & Development, 2009
- A reliable cell-based assay for testing unclassified TSC2 gene variantsEuropean Journal of Human Genetics, 2008
- Analysis of 65 tuberous sclerosis complex (TSC) patients byTSC2DGGE,TSC1/TSC2MLPA, andTSC1long-range PCR sequencing, and report of 28 novel mutationsHuman Mutation, 2005
- TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signallingNature, 2002
- Comprehensive Mutation Analysis of TSC1 and TSC2—and Phenotypic Correlations in 150 Families with Tuberous SclerosisAmerican Journal of Human Genetics, 1999
- Comprehensive mutation analysis of TSC1 using two-dimensional DNA electrophoresis with DGGEAnnals of Human Genetics, 1998
- Prevalence of tuberous sclerosis estimated by capture-recapture analysisThe Lancet, 1998
- Identification and characterization of the tuberous sclerosis gene on chromosome 16Cell, 1993
- Genetic aspects of tuberous sclerosis in the west of Scotland.Journal of Medical Genetics, 1989